Effect of obesity on risk of hospitalization, surgery, and serious infection in biologic-treated patients with inflammatory bowel diseases: a CA-IBD cohort study
METHODS: We created an EHR-based cohort of adult patients with IBD who were new
users of biologic agents (tumor necrosis factor [TNF-α] antagonists, ustekinumab, and …
users of biologic agents (tumor necrosis factor [TNF-α] antagonists, ustekinumab, and …
Effect of Obesity on Risk of Hospitalization, Surgery, and Serious Infection in Biologic-Treated Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study.
P Gu, J Luo, J Kim, P Paul, B Limketkai… - The American Journal …, 2022 - europepmc.org
Methods We created an EHR-based cohort of adult patients with IBD who were new users of
biologic agents (tumor necrosis factor [TNF-α] antagonists, ustekinumab, and vedolizumab) …
biologic agents (tumor necrosis factor [TNF-α] antagonists, ustekinumab, and vedolizumab) …
Effect of Obesity on Risk of Hospitalization, Surgery, and Serious Infection in Biologic-Treated Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study
P Gu, J Luo, J Kim, P Paul, B Limketkai… - … American Journal of …, 2022 - ingentaconnect.com
INTRODUCTION: Obesity is variably associated with treatment response in biologic-treated
patients with inflammatory bowel diseases (IBD). We evaluated the association between …
patients with inflammatory bowel diseases (IBD). We evaluated the association between …
Effect of obesity on risk of hospitalization, surgery, and serious infection in biologic-treated patients with inflammatory bowel diseases: a CA-IBD cohort study.
P Gu, JM Luo, JM Kim, PM Paul, B Limketkai, JS Sauk… - 2022 - cabidigitallibrary.org
INTRODUCTION: Obesity is variably associated with treatment response in biologic-treated
patients with inflammatory bowel diseases (IBD). We evaluated the association between …
patients with inflammatory bowel diseases (IBD). We evaluated the association between …
Effect of Obesity on Risk of Hospitalization, Surgery, and Serious Infection in Biologic-Treated Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study
P Gu, J Luo, J Kim, P Paul, B Limketkai… - Official journal of the …, 2022 - journals.lww.com
METHODS: We created an EHR-based cohort of adult patients with IBD who were new
users of biologic agents (tumor necrosis factor [TNF-α] antagonists, ustekinumab, and …
users of biologic agents (tumor necrosis factor [TNF-α] antagonists, ustekinumab, and …
Effect of Obesity on Risk of Hospitalization, Surgery, and Serious Infection in Biologic-Treated Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study
P Gu, L Jiyu, J Kim, P Paul, L Berkeley… - … American Journal of …, 2022 - search.proquest.com
METHODS: We created an EHR-based cohort of adult patients with IBD who were new
users of biologic agents (tumor necrosis factor [TNF-α] antagonists, ustekinumab, and …
users of biologic agents (tumor necrosis factor [TNF-α] antagonists, ustekinumab, and …
Effect of Obesity on Risk of Hospitalization, Surgery, and Serious Infection in Biologic-Treated Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study
P Gu, J Luo, J Kim, P Paul… - American Journal …, 2022 - scholars.northwestern.edu
INTRODUCTION: Obesity is variably associated with treatment response in biologic-treated
patients with inflammatory bowel diseases (IBD). We evaluated the association between …
patients with inflammatory bowel diseases (IBD). We evaluated the association between …
Effect of Obesity on Risk of Hospitalization, Surgery, and Serious Infection in Biologic-Treated Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study
P Gu, J Luo, J Kim, P Paul… - The American …, 2022 - pubmed.ncbi.nlm.nih.gov
Introduction Obesity is variably associated with treatment response in biologic-treated
patients with inflammatory bowel diseases (IBD). We evaluated the association between …
patients with inflammatory bowel diseases (IBD). We evaluated the association between …